FlucoLich medications OTC
Fluconazole may FlucoLich the complete concentrations of orally administered tacrolimus up prescription 5 times due to inhibition of tacrolimus metabolism through CYP3A4 in the intestines. This list is not complete and many other drugs can interact with fluconazole.
Possible side effects of FlucoLich include:
- nausea and vomiting
- dark urine
- dry mouth
- change in taste or bad, unusual, or unpleasant (after) taste
- seeing, hearing, or feeling things that are not there
FlucoLich is used to treat diseases such as: Blastomycosis, Bone Marrow Transplantation, Candida Urinary Tract Infection, Candidemia, Chronic Mucocutaneous Candidiasis, Coccidioidomycosis, Coccidioidomycosis, Meningitis, Cryptococcal Meningitis, Immunocompetent Host, Cryptococcal Meningitis, Immunosuppressed Host, Cryptococcosis, Esophageal Candidiasis, Fungal Infection Prophylaxis, Fungal Infection, Internal and Disseminated, Fungal Peritonitis, Fungal Pneumonia, Histoplasmosis, Onychomycosis, Fingernail, Onychomycosis, Toenail, Oral Thrush, Sporotrichosis, Systemic Candidiasis, Tinea Corporis, Tinea Cruris, Tinea Versicolor, Vaginal Yeast Infection.
How to Use
- It is also strongly recommended not to increase or lower the dose of the recommended amount if you have not spoken to your treating doctor about this change or to just stop taking this medication completely, as this may result in increased side effects.
Dosage & Overdose
The usual dose is one capsule of either 30 mg or 60 mg daily.
- An interruption of therapy, dose reduction, or discontinuation of therapy may be necessary for crizotinib patients if QT prolongation occurs.
- It helps prevent the body from absorbing too much salt, which can cause fluid retention.
- It is very important for women with epilepsy to talk to the doctor responsible for their epilepsy treatment before becoming pregnant.
- If progestins were given to the mother in that same dosage, serious birth defects could occur.
- If these drugs are used together, counsel the patient about the risk of pregnancy and teratogenic effects, and instruct the patient to notify the prescriber if they experience breakthrough bleeding while receiving these drugs together.